Lv1
10 积分 2023-04-04 加入
IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
3小时前
待确认
Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy
25天前
已完结
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
1个月前
已完结
Humanization of T cell–mediated immunity in mice
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
2个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
2个月前
已关闭
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
2个月前
已完结
Transmembrane domain–driven PD-1 dimers mediate T cell inhibition
2个月前
已完结
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
2个月前
已完结
Application of CAR‐T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment
5个月前
已完结
皖公网安备34019202002308
